• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies

    Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics

    NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidisciplinary research questions, generate insights, and integrate that information back into their existing Oracle Health and Life Sciences applications. As a result, life sciences organizations can more accurately identify market needs, assess commercial viability, and optimize therapeutic launch strategies. This innovation is yet another step in Oracle's vision to bridge the gap between clinical research and clinical care.

    (PRNewsfoto/Oracle)

    "Oracle continues to deliver game-changing products that modernize and enhance clinical research and tighten the connection between bench and bedside," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "With Oracle Analytics Intelligence for Life Sciences, we are breaking down the silos that have stifled innovation in the industry and are delivering the tools and intelligence needed to help advance insights and therapies with speed and precision."

    Supported by a wide variety of real-world data sources, such as CancerMPact and multiomics, the platform delivers actionable insights out of the box with pre-built curated datasets, data pipelines, adaptable models, and analytics for determining patient experience, safety monitoring, therapy effectiveness, and brand measurement. Oracle Analytics Intelligence for Life Sciences customers who use the Oracle Learning Health Network will also have continuously updated anonymized Oracle Real World Data (ORWD) available in their analytics environment, which broadens their access to even more information.

    Oracle Analytics Intelligence for Life Sciences is powered by Oracle Health Data Intelligence (HDI). Built on the security and high performance of Oracle Cloud Infrastructure (OCI), Oracle Health Data Intelligence integrates, secures, and analyzes data from a broad range of sources including electronic health records (EHR), enterprise applications, insurance claims, and demographic records, to provide a more comprehensive view of individual patients and overall population health.

    This proven, EHR-agnostic platform is a continuously learning ecosystem that powers provider applications to support intelligent clinical decision-making, care coordination, and value-based care delivery. With Oracle Analytics Intelligence for Life Sciences, Oracle is now extending this platform to enable clinical research and insight generation, which feeds back into the HDI ecosystem in a continuous learning loop.

    The platform was developed in coordination with Oracle's globally renowned Research Services division, merging cutting-edge technology with deep domain expertise. This collaboration brings together top life sciences experts, including the oncology researchers behind CancerMPact, to deliver a groundbreaking platform that advances insights and therapies with unmatched speed and precision.

    For more information about Oracle Analytics Intelligence for Life Sciences visit: https://www.oracle.com/life-sciences/

    To join segments of the Oracle Health Summit virtually, visit: https://www.oracle.com/health/health-summit/

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements – empowering the life sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-launches-ai-powered-oracle-analytics-intelligence-for-life-sciences-302291197.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What is the recent product launched by Oracle for life sciences?

      Oracle has launched the Oracle Analytics Intelligence for Life Sciences, an AI-powered platform designed to unite disparate data sets and accelerate insight generation for life sciences organizations.

    • What types of data sources does the Oracle Analytics Intelligence for Life Sciences utilize?

      The new platform integrates data from various sources, including electronic health records, insurance claims, and demographic records, to provide comprehensive insights on patient experiences and therapy effectiveness.

    • How does Oracle Analytics Intelligence for Life Sciences intend to impact therapeutic launch strategies?

      This platform aims to bridge the gap between clinical research and clinical care, allowing organizations to identify market needs, assess the commercial viability of treatments, and optimize therapeutic launch strategies.

    • What functionalities does the Oracle Analytics Intelligence platform offer to its users?

      The platform supports multidisciplinary research questions and continuously updates insights using real-world data to improve decision-making and patient care outcomes.

    • What is Oracle's broader vision with the introduction of the Analytics Intelligence for Life Sciences?

      The launch is part of Oracle's strategy to modernize clinical research and tightens the connection between research and actual patient care through advanced analytics and data integration.

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    7/20/2026$145.00Hold
    CLSA
    6/11/2026$200.00 → $220.00Outperform
    BMO Capital Markets
    5/12/2026$210.00 → $235.00Outperform
    Oppenheimer
    5/7/2026$255.00Neutral → Buy
    Arete
    4/24/2026$225.00Outperform
    Wedbush
    4/10/2026Buy → Neutral
    Cleveland Research
    3/24/2026$200.00Buy
    BofA Securities
    3/11/2026$210.00Neutral → Overweight
    Analyst
    More analyst ratings

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Betterware de México, S.A.P.I. de C.V. Announces Strategic Board Appointments and Retains New Innovation Strategic Consultant

    Betterware de México, S.A.P.I. de C.V. (NYSE:BWMX) ("BeFra" or the "Company") announces today some changes to its Board of Directors and retains strategic consultant related to product innovation. Changes in the Board of Directors The Company announced the appointment of two accomplished executives to its Board of Directors as approved in its shareholder meeting: Mr. Juan Pajón brings extensive experience in digital transformation and technology leadership. He currently serves as Head of Customer Success and Global Innovation at Oracle Corporation (NYSE:ORCL) and previously served as Global Chief Technology Officer of Grupo Bimbo (BMV:BIMBO) and Chief Information Officer for LATAM GS

    7/21/26 8:30:00 AM ET
    $BWMX
    $ORCL
    $PPC
    Catalog/Specialty Distribution
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    Tradr's 2X Short Leveraged ETFs on AAOI and ORCL Begin Trading

    The first 2X short ETFs on Applied Optoelectronics and Oracle are now availableFunds represent first-to-market inverse strategies on Applied Optoelectronics and Oracle CorporationNEW YORK, July 15, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched two new leveraged ETFs on the stocks of Applied Optoelectronics and Oracle Corporation. The Cboe-listed funds seek to deliver two times short (-200%) the daily performance of their underlying target stocks.AAOZ and ORCZ give sophisticated traders efficient tools to capitalize on downside opportunitiesThe following ETFs are expected to open for trading today:Tradr 2X Sho

    7/15/26 6:46:00 AM ET
    $AAOI
    $ORCL
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Oracle Introduces AI-Native Builder Experience to Create and Run Agentic Applications in Oracle Fusion Applications

    New no-code and pro-code capabilities enable customers and partners to build Fusion Agentic Applications backed by specialized agent teams, Fusion business objects, workflows, approvals, governance, and auditabilityWith the new AI Studio Skill, developers can now use familiar tools such as VS Code, OpenAI Codex, Claude Code, CLIs, and Git to build agentic applications within the same Fusion-native framework for governance that Oracle usesAUSTIN, Texas, July 14, 2026 /PRNewswire/ -- Oracle today announced a new AI-native builder experience for Oracle AI Agent Studio for Fusion Applications that enables customers and partners to create and run Fusion Agentic Applications natively within Oracle

    7/14/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    SEC Filings

    View All

    SEC Form 144 filed by Oracle Corporation

    144 - ORACLE CORP (0001341439) (Subject)

    6/24/26 4:35:45 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Oracle Corporation

    424B5 - ORACLE CORP (0001341439) (Filer)

    6/23/26 8:52:53 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by Oracle Corporation

    10-K - ORACLE CORP (0001341439) (Filer)

    6/22/26 4:12:40 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/14/25 4:41:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CLSA initiated coverage on Oracle with a new price target

    CLSA initiated coverage of Oracle with a rating of Hold and set a new price target of $145.00

    7/20/26 8:57:50 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $220.00 from $200.00 previously

    6/11/26 7:53:42 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oppenheimer reiterated coverage on Oracle with a new price target

    Oppenheimer reiterated coverage of Oracle with a rating of Outperform and set a new price target of $235.00 from $210.00 previously

    5/12/26 8:03:13 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Vice Chairman Henley Jeffrey exercised 400,000 shares at a strike of $40.93 and sold $63,664,040 worth of shares (400,000 units at $159.16) as part of a pre-agreed trading plan (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    6/26/26 4:52:25 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Rusckowski Stephen H

    4 - ORACLE CORP (0001341439) (Issuer)

    6/2/26 5:48:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W converted options into 2,114 shares, increasing direct ownership by 5% to 40,689 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    6/2/26 5:46:04 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    View All

    Betterware de México, S.A.P.I. de C.V. Announces Strategic Board Appointments and Retains New Innovation Strategic Consultant

    Betterware de México, S.A.P.I. de C.V. (NYSE:BWMX) ("BeFra" or the "Company") announces today some changes to its Board of Directors and retains strategic consultant related to product innovation. Changes in the Board of Directors The Company announced the appointment of two accomplished executives to its Board of Directors as approved in its shareholder meeting: Mr. Juan Pajón brings extensive experience in digital transformation and technology leadership. He currently serves as Head of Customer Success and Global Innovation at Oracle Corporation (NYSE:ORCL) and previously served as Global Chief Technology Officer of Grupo Bimbo (BMV:BIMBO) and Chief Information Officer for LATAM GS

    7/21/26 8:30:00 AM ET
    $BWMX
    $ORCL
    $PPC
    Catalog/Specialty Distribution
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    Oracle Strengthens Defense Ecosystem to Help Emerging Technology Companies Scale Mission-Ready Capabilities

    Oracle, Defence Holdings, and Shield Reply collaborate to help emerging defense technology companies bring mission-ready AI, cyber, and operational capabilities to the US and allied nations BRUSSELS, June 25, 2026 /PRNewswire/ -- At Oracle Defence Tech Summit 2026, Oracle today announced the third cohort of the Oracle Defense Ecosystem, adding 10 defense technology companies delivering mission-critical AI, cyber, secure communications, operational intelligence, autonomous systems, and mission support capabilities for the US and allied nations. The Oracle Defense Ecosystem connects Oracle's distributed cloud and AI infrastructur

    6/25/26 2:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    FiscalNote Appoints Key Compton as President and Chief Executive Officer

    Investor since 2020 and board member since 2021 tapped to lead company's return to growth FiscalNote Holdings, Inc. (OTC:NOTE), a global leader in AI-driven policy and regulatory intelligence, today announced that Key Compton has been appointed President and Chief Executive Officer. Compton, who has served as a FiscalNote board member since 2021 and as Audit Committee Chair, succeeds Josh Resnik, who in eight years of senior leadership built FiscalNote into a publicly traded, AI-driven policy intelligence leader, launched its flagship PolicyNote platform, and drove other key new initiatives such as the expansion of its API ecosystem. Resnik will support Compton’s transition into the role

    6/24/26 9:00:00 AM ET
    $NOTE
    $SPIR
    $LPSN
    Real Estate
    Telecommunications Equipment
    Consumer Discretionary
    Computer Software: Prepackaged Software

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/23 4:31:02 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/22 8:28:11 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Financials

    Live finance-specific insights

    View All

    Oracle Announces Record Q4 and FY 2026 Results Driven by Cloud Infrastructure & Cloud Applications

    Record Remaining Performance Obligations grew $85 billion in Q4 from $553 billion to $638 billionRecord Q4 Earnings per Share GAAP up 21% USD to $1.45, non-GAAP up 24% USD to $2.111Record Q4 Total Revenues $19.2 billion, up 21% USD, and up 20% constant currencyRecord Q4 Total Cloud Revenues $9.9 billion, up 47% USD, and up 46% constant currencyQ4 Cloud Infra (IaaS) Revenue $5.8 billion, up 93% USD, and up 92% constant currencyQ4 Cloud Apps (SaaS) Revenue $4.1 billion, up 10% USD, and up 9% constant currencyRecord FY 2026 Earnings per Share GAAP up 34% USD to $5.83, non-GAAP up 27% USD to $7.631Record FY 2026 Total Revenues $67.4 billion, up 17% USD, and up 16% constant currencyRecord FY 2026

    6/10/26 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its Fourth Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on June 10, 2026, After the Close of the MarketAUSTIN, Texas, June 1, 2026 /PRNewswire/ -- Oracle Corporation today announced that its fourth quarter fiscal year 2026 results will be released on Wednesday, June 10th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About OracleOracle offers integrated suites of applications plus secure, autonomous inf

    6/1/26 4:01:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Announces Fiscal Year 2026 Third Quarter Financial Results

    Q3 Remaining Performance Obligations $553 billion, up 325% year-over-year in USDQ3 GAAP Earnings per Share up 24% to $1.27, Non-GAAP Earnings per Share up 21% to $1.79Q3 Total Revenue $17.2 billion, up 22% in USD and up 18% in constant currencyQ3 Cloud Revenue (IaaS plus SaaS) $8.9 billion, up 44% in USD and up 41% in constant currency Q3 Cloud Infrastructure Revenue (IaaS) $4.9 billion, up 84% in USD and up 81% in constant currencyQ3 Oracle Cloud Database (IaaS) Revenue up 35%, Multicloud Database Revenue up 531% in USDQ3 Cloud Application (SaaS) Revenue $4.0 billion, up 13% in USD and up 11% in constant currencyQ3 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 17% in USD and up 14% in co

    3/10/26 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology